Logo image of BLV.PA

BELIEVE SA (BLV.PA) Stock Fundamental Analysis

EPA:BLV - Euronext Paris - Matif - FR0014003FE9 - Common Stock - Currency: EUR

14.28  -0.02 (-0.14%)

Fundamental Rating

3

BLV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 44 industry peers in the Entertainment industry. BLV may be in some trouble as it scores bad on both profitability and health. BLV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BLV has reported negative net income.
In the past year BLV had a positive cash flow from operations.
BLV had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BLV reported negative operating cash flow in multiple years.
BLV.PA Yearly Net Income VS EBIT VS OCF VS FCFBLV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

With a Return On Assets value of -1.20%, BLV is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
BLV has a worse Return On Equity (-3.51%) than 60.00% of its industry peers.
Industry RankSector Rank
ROA -1.2%
ROE -3.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLV.PA Yearly ROA, ROE, ROICBLV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

With a Gross Margin value of 32.47%, BLV is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
BLV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BLV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-1.64%
BLV.PA Yearly Profit, Operating, Gross MarginsBLV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

BLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLV.PA Yearly Shares OutstandingBLV.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M
BLV.PA Yearly Total Debt VS Total AssetsBLV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that BLV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLV (1.71) is better than 70.00% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that BLV is not too dependend on debt financing.
BLV has a better Debt to Equity ratio (0.06) than 92.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACCN/A
WACC7.65%
BLV.PA Yearly LT Debt VS Equity VS FCFBLV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

BLV has a Current Ratio of 0.84. This is a bad value and indicates that BLV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BLV (0.84) is comparable to the rest of the industry.
A Quick Ratio of 0.83 indicates that BLV may have some problems paying its short term obligations.
BLV's Quick ratio of 0.83 is in line compared to the rest of the industry. BLV outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.83
BLV.PA Yearly Current Assets VS Current LiabilitesBLV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

BLV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.08%, which is quite impressive.
BLV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
Measured over the past years, BLV shows a very strong growth in Revenue. The Revenue has been growing by 29.90% on average per year.
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2128.99%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y25.87%
Revenue growth 5Y29.9%
Sales Q2Q%118.68%

3.2 Future

BLV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 59.99% yearly.
Based on estimates for the next years, BLV will show a quite strong growth in Revenue. The Revenue will grow by 15.08% on average per year.
EPS Next Y206.21%
EPS Next 2Y114.19%
EPS Next 3Y84.42%
EPS Next 5Y59.99%
Revenue Next Year15.05%
Revenue Next 2Y16.64%
Revenue Next 3Y15.23%
Revenue Next 5Y15.08%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLV.PA Yearly Revenue VS EstimatesBLV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLV.PA Yearly EPS VS EstimatesBLV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 52.76 indicates a quite expensive valuation of BLV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLV indicates a slightly more expensive valuation: BLV is more expensive than 60.00% of the companies listed in the same industry.
BLV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 92.74.
Industry RankSector Rank
PE N/A
Fwd PE 52.76
BLV.PA Price Earnings VS Forward Price EarningsBLV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLV indicates a slightly more expensive valuation: BLV is more expensive than 67.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.52
BLV.PA Per share dataBLV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

BLV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BLV's earnings are expected to grow with 84.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.19%
EPS Next 3Y84.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELIEVE SA

EPA:BLV (2/4/2025, 7:00:00 PM)

14.28

-0.02 (-0.14%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23 2024-10-23
Earnings (Next)N/A N/A
Inst Owners3.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.44B
Analysts70
Price Target16.27 (13.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.21%
PT rev (3m)1.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)28.21%
EPS NY rev (3m)28.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.76
P/S 1.53
P/FCF N/A
P/OCF 53.62
P/B 3.77
P/tB 13.91
EV/EBITDA 38.52
EPS(TTM)-0.13
EYN/A
EPS(NY)0.27
Fwd EY1.9%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.27
OCFY1.86%
SpS9.33
BVpS3.78
TBVpS1.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.2%
ROE -3.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.47%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y-1.64%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.67
Cap/Depr 71.01%
Cap/Sales 4.91%
Interest Coverage N/A
Cash Conversion 80.85%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.83
Altman-Z 1.71
F-Score5
WACC7.65%
ROIC/WACCN/A
Cap/Depr(3y)73.39%
Cap/Depr(5y)102.42%
Cap/Sales(3y)4.6%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2128.99%
EPS Next Y206.21%
EPS Next 2Y114.19%
EPS Next 3Y84.42%
EPS Next 5Y59.99%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y25.87%
Revenue growth 5Y29.9%
Sales Q2Q%118.68%
Revenue Next Year15.05%
Revenue Next 2Y16.64%
Revenue Next 3Y15.23%
Revenue Next 5Y15.08%
EBIT growth 1Y-568.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4709.51%
EBIT Next 3Y334.67%
EBIT Next 5Y168.98%
FCF growth 1Y-279.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.65%
OCF growth 3YN/A
OCF growth 5Y-15.28%